BII
MCRB icon

Bainco International Investors’s Seres Therapeutics MCRB Stock Holding History

Bainco International Investors’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$8K Buy
+15
New +$8.78K ﹤0.01% 182
2020
Q2 		– Sell
-15
Closed -$1K – 184
2020
Q1 		$1K Buy
+15
New +$1.01K ﹤0.01% 270

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bainco International Investors's MCRB Position: Q4 2020 in Review

Bainco International Investors opened a new position in Seres Therapeutics (MCRB) in Q4 2020: 15 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #182 among its holdings. This is a return to the name: Bainco International Investors previously reported a position in MCRB as recently as Q1 2020.

Bainco International Investors first reported a position in MCRB in Q1 2020 and has held it in 2 quarters since. 152 funds tracked by Wall St. Rank hold MCRB as of Q4 2020.

  • Bainco International Investors held 15 shares of Seres Therapeutics worth $8K as of Q4 2020.
  • Seres Therapeutics was a new Bainco International Investors position in Q4 2020.
  • Seres Therapeutics made up ﹤0.01% of Bainco International Investors's portfolio in Q4 2020, its #182 holding.
  • Bainco International Investors first reported a position in Seres Therapeutics in Q1 2020 and has held it in 2 quarters since.
  • 152 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2020.

Based on Bainco International Investors's 13F filing for Q4 2020, filed 12 Jan 2021.